Pacira BioSciences sells pain treatments such as EXPAREL and ZILRETTA to patients and healthcare providers. It last closed at $36.48 on Nov 16, up 0.05% on the day. The next earnings report for PCRX is expected around Thu, Feb 4, 2027, after the close. For the quarter ended Sep 2026, PCRX reported EPS of $0.70 on revenue of $176.7M, with revenue down 1.6% from a year ago. Over its last 8 reports the stock moved an average of 4.7% the session after earnings. Over the last 12 months PCRX insiders bought $0 of stock on the open market and sold $2.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is PCRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PCRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PCRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PCRX · as of the Nov 16 close · updated each morning
Uptrend, overbought
The stock is 0% above its 20 day and 14% above its 50 day average. It is 29% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 83), overbought. The nearest support is the 20 day average at $36.41, and the nearest resistance the Pivot R1 at $36.49.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 0.7%/day
Key levels
$36.6652 week high+0.5%
$36.50Swing high (Nov 10)+0.1%
$36.49Pivot R1+0.0%
$36.48Pivot+0.0%
$36.48Pivot S1+0.0%
$36.48Last close
$36.4120 day average−0.2%
$36.38Swing low (Nov 4)−0.3%
$31.3950 day average−14.0%
$28.41100 day average−22.1%
$25.73200 day average−29.5%
$18.8052 week low−48.5%
Indicators
RSI (14)
82.85
Overbought above 70
Overbought
MACD
1.23
Below its signal line
Bearish
Stochastic
77.8
Middle of its range
Neutral
ADX (14)
69.7
Strong uptrend
Williams %R
-13.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
127.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+0.2%
Change over 10 sessions
Bullish
ATR (14)
$0.26
Typical daily range, 0.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityLow, 4.7%/day
Key levels
$36.6652 week high+0.5%
$36.50Swing high (Nov 10)+0.1%
$36.49Pivot R1+0.0%
$36.48Pivot+0.0%
$36.48Pivot S1+0.0%
$36.48Last close
$36.4120 day average−0.2%
$36.38Swing low (Nov 4)−0.3%
$31.3950 day average−14.0%
$28.41100 day average−22.1%
$25.73200 day average−29.5%
$18.8052 week low−48.5%
Indicators
RSI (14)
77.64
Overbought above 70
Overbought
MACD
3.38
Above its signal line
Bullish
Stochastic
98.5
Near the top of its range
Overbought
ADX (14)
30.4
Trending up
Williams %R
-1.4
Oversold below −80, overbought above −20
Overbought
CCI (20)
103.9
Oversold below −100, overbought above 100
Overbought
Rate of change
+43.9%
Change over 10 sessions
Bullish
ATR (14)
$1.72
Typical daily range, 4.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for PCRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PCRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PCRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PCRXHow many large options trades hit PCRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PCRX in the last 90 days.
From SEC Form 4 filings by PCRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PCRX is in one of them and how their past PCRX trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Pacira BioSciences
Pacira BioSciences is a pharmaceutical company based in Brisbane, California. It sells pain treatments that do not rely on opioids. Its main products are EXPAREL, a local pain treatment used around surgery that works over an extended period, ZILRETTA, a knee injection that releases medicine over time for osteoarthritis pain, and the iovera handheld device, which uses cold to block pain signals in targeted nerves. Its customers include patients and the healthcare providers who treat them.